NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,194 Cr | ₹1,751 Cr | ₹912 Cr | ₹264 Cr | ₹604 Cr |
What is the latest Operating Profit of NATCO PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹2,194 Cr |
| Mar2024 | ₹1,751 Cr |
| Mar2023 | ₹912 Cr |
| Mar2022 | ₹264 Cr |
| Mar2021 | ₹604 Cr |
How is Operating Profit of NATCO PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,194 Cr | 25.26 | |
| Mar2024 | ₹1,751 Cr | 92.10 | |
| Mar2023 | ₹912 Cr | 246.00 | |
| Mar2022 | ₹264 Cr | -56.36 | |
| Mar2021 | ₹604 Cr | - | |
Compare Operating Profit of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,072.2 Cr | 0.7% | -7.1% | -26.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,847.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,745.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,346.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,075.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,507.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 0.7% |
-7.1% |
-26.5% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses